About Modifi Bio
Modifi Bio is a company based in New Haven (United States) founded in 2021 by Ranjit Bindra and Kingson Lin was acquired by Merck in October 2024.. Modifi Bio has raised $11.7 million across 3 funding rounds from investors including Merck, BrightEdge and Yale University. Modifi Bio operates in a competitive market with competitors including Biodexa Pharmaceuticals, OncoSynergy, Plex Pharmaceuticals, Flag Therapeutics and Purposeful, among others.
- Headquarter New Haven, United States
- Founders Ranjit Bindra, Kingson Lin
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Modifi Biosciences, Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Funding Insights of Modifi Bio
Modifi Bio has successfully raised a total of $11.7M across 3 strategic funding rounds. The most recent funding activity was a Seed round of $995.5 thousand completed in August 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Seed — $995,503
-
First Round
First Round
(29 Jul 2022)
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2024 | Amount | Seed - Modifi Bio | Valuation |
investors |
|
| Oct, 2023 | Amount | Seed - Modifi Bio | Valuation | Pathway Bioventures , The Sontag Foundation | |
| Jul, 2022 | Amount | Seed - Modifi Bio | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Modifi Bio
Modifi Bio has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include Merck, BrightEdge and Yale University. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Life science companies are targeted for private equity investments.
|
Founded Year | Domain | Location | |
|
Venture capital services for biotech, IT, and innovative sectors in Connecticut.
|
Founded Year | Domain | Location | |
|
Private equity and debt investments are focused on multiple sectors.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Modifi Bio
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Modifi Bio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Modifi Bio Comparisons
Competitors of Modifi Bio
Modifi Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biodexa Pharmaceuticals, OncoSynergy, Plex Pharmaceuticals, Flag Therapeutics and Purposeful, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutics for aggressive rare brain cancers are developed.
|
|
| domain | founded_year | HQ Location |
Resistance mechanism inhibitors for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Discovering small molecules for diseases caused by protein misfolding such as Parkinson's.
|
|
| domain | founded_year | HQ Location |
Small molecule therapeutics for difficult-to-treat cancers are developed.
|
|
| domain | founded_year | HQ Location |
Purposeful is engaged in discovering treatments for rare diseases.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Modifi Bio
Frequently Asked Questions about Modifi Bio
When was Modifi Bio founded?
Modifi Bio was founded in 2021 and raised its 1st funding round 1 year after it was founded.
Where is Modifi Bio located?
Modifi Bio is headquartered in New Haven, United States. It is registered at New Haven, Connecticut, United States.
Is Modifi Bio a funded company?
Modifi Bio is a funded company, having raised a total of $11.7M across 3 funding rounds to date. The company's 1st funding round was a Seed of $6.4M, raised on Jul 29, 2022.
What does Modifi Bio do?
Developer of therapeutics for the treatment of cancer. The company focuses on developing therapeutics that uniquely target specific acquired cancer cell DNA mutations for the treatment of all cancer types.
Who are the top competitors of Modifi Bio?
Modifi Bio's top competitors include Diakonos, Biodexa Pharmaceuticals and OncoSynergy.
Who are Modifi Bio's investors?
Modifi Bio has 9 investors. Key investors include Merck, BrightEdge, Yale University, HighCape Capital, and The Sontag Foundation.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.